biomedin215-2011
Differences
This shows you the differences between two versions of the page.
|
biomedin215-2011 [2012/08/10 10:56] nigam created |
biomedin215-2011 [2012/08/10 10:57] nigam [Schedule and Syllabus] |
||
|---|---|---|---|
| Line 25: | Line 25: | ||
| - | ^ Lecture^ Learning Objective^ Module^ Homework and Project^ Date^ HW Dataset^ 2012 Date^ | + | ^ Lecture^ Learning Objective^ Module^ Homework and Project^ Date^ HW Dataset^ |
| - | | 1| Introduction, | + | | 1| Introduction, |
| - | | 2| Data mining in medicine -I | Medical Dataminer' | + | | 2| Data mining in medicine -I | Medical Dataminer' |
| - | | 3| Data mining in medicine - II | Medical Dataminer' | + | | 3| Data mining in medicine - II | Medical Dataminer' |
| - | | 4| Health Care Utilization Databases + Review of relevant Ontologies | Medical Dataminer' | + | | 4| Health Care Utilization Databases + Review of relevant Ontologies | Medical Dataminer' |
| ^ - ^ ^ ^ ^ ^ ^ | ^ - ^ ^ ^ ^ ^ ^ | ||
| - | | 5| Introduction to Drug Safety Surveillance| Drug Safety Surveillance| HW-1 out|10/ | + | | 5| Introduction to Drug Safety Surveillance| Drug Safety Surveillance| HW-1 out|10/ |
| - | | 6| State of the art and Exemplar paper| Drug Safety Surveillance| |10/ | + | | 6| State of the art and Exemplar paper| Drug Safety Surveillance| |10/ |
| - | | 7| Other methods| Drug Safety Surveillance| |10/ | + | | 7| Other methods| Drug Safety Surveillance| |10/ |
| - | | 8| Other possible methods| Drug Safety Surveillance| |10/ | + | | 8| Other possible methods| Drug Safety Surveillance| |10/ |
| - | | 9| Project propsals| Drug Safety Surveillance| HW-1 due|10/ | + | | 9| Project propsals| Drug Safety Surveillance| HW-1 due|10/ |
| ^ - ^ ^ ^ ^ ^ ^ | ^ - ^ ^ ^ ^ ^ ^ | ||
| - | | 10| Introduction to Predicting Readmissions | Predictive data-mining| |10/ | + | | 10| Introduction to Predicting Readmissions | Predictive data-mining| |10/ |
| - | | 11| State of the art (Readmissions) | Predictive data-mining|HW-2 out|11/ | + | | 11| State of the art (Readmissions) | Predictive data-mining|HW-2 out|11/ |
| - | | 12| Intro. to Co-morbidities and Exemplar paper (Discharge decision / Survival)| Predictive data-mining| |11/ | + | | 12| Intro. to Co-morbidities and Exemplar paper (Discharge decision / Survival)| Predictive data-mining| |11/3/2011| | |
| - | | 13| State of the art (Discharge decision / Survival)| Predictive data-mining| |11/ | + | | 13| State of the art (Discharge decision / Survival)| Predictive data-mining| |11/8/2011| | |
| ^ - ^ ^ ^ ^ ^ ^ | ^ - ^ ^ ^ ^ ^ ^ | ||
| - | | 14| Clinical Text Mining: Goals and Key Problems| Clinical Text Mining| |11/ | + | | 14| Clinical Text Mining: Goals and Key Problems| Clinical Text Mining| |11/ |
| - | | 15| History and Review of the state of the art| Clinical Text Mining| HW-2 due, HW-3 out|11/ | + | | 15| History and Review of the state of the art| Clinical Text Mining| HW-2 due, HW-3 out|11/ |
| - | | 16| i2b2 NLP challenges| Clinical Text Mining| |11/ | + | | 16| i2b2 NLP challenges| Clinical Text Mining| |11/ |
| - | | 17| Non traditional approaches; How to improve on existing methods| Clinical Text Mining| HW-3 due |11/ | + | | 17| Non traditional approaches; How to improve on existing methods| Clinical Text Mining| HW-3 due |11/ |
| - | | 18| Wrap-up: What did we learn? What questions remain? | + | | 18| Wrap-up: What did we learn? What questions remain? |
| ^ - ^ ^ ^ ^ ^ ^ | ^ - ^ ^ ^ ^ ^ ^ | ||
| - | | 19| PROJECT PRESENTATIONS| | Final Project|12/ | + | | 19| PROJECT PRESENTATIONS| | Final Project|12/ |
| - | | 20| PROJECT PRESENTATIONS| | Final Project|12/ | + | | 20| PROJECT PRESENTATIONS| | Final Project|12/ |
| ====== Useful References ====== | ====== Useful References ====== | ||
biomedin215-2011.txt · Last modified: 2012/08/10 10:57 by nigam
Page Tools
